1. A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years. (10th April 2015) Authors: Lang, A.‐S.; Mounier, M.; Roques, M.; Chretien, M. L.; Boulin, M. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 40:Number 4(2015:Aug.) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years. (10th April 2015) Authors: Lang, A.‐S.; Mounier, M.; Roques, M.; Chretien, M. L.; Boulin, M. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 40:Number 4(2015:Aug.) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hemorrhagic transformation after stroke: inter‐ and intrarater agreement. (7th December 2018) Authors: Guenego, A.; Lecler, A.; Raymond, J.; Sabben, C.; Khoury, N.; Premat, K.; Botta, D.; Boisseau, W.; Maïer, B.; Ciccio, G.; Redjem, H.; Smajda, S.; Ducroux, C.; Di Meglio, L.; Davy, V.; Olivot, J. M.; Wang, A.; Duplantier, J.; Roques, M.; Krystal, S. Journal: European journal of neurology Issue: Volume 26:Number 3(2019) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0091 Brainstem toxicity after proton or photon therapy in children with localized intracranial ependymoma. (May 2022) Authors: Dalmasso, C.; Alapetite, C.; Bolle, S.; Tensaouti, F.; Lusque, A.; Desrousseaux, J.; Claude, L.; Doyen, J.; Supiot, S.; Bernier-Chastagner, V.; Leblond, P.; Ducassou, A.; Péran, P.; Sévely, A.; Roques, M.; Laprie, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗